Completed collaborations

PolyTherics has previously collaborated with the following companies:

Alligator Biosciences to develop the next generation of protein-based therapeutics. See press release.

Avecia to develop the next generation of antibody fragments as therapeutic agents; the project was funded jointly by the companies and was supported by a TSB grant. See press release.

Biocompatibles to enable Biocompatibles’ phosphorylcholine polymer technology to be applied to therapeutic proteins through use of PolyTherics’ TheraPEG™ technology. See press release.

GlycoForm to PEGylate an aglycosyl natural erythropoietin (EPO); the project was funded jointly by the companies and was supported by a TSB grant. Contact Business Development if you are interested in supporting the further development of a PEGylated aglycosyl EPO.

Minapharm Pharmaceuticals, a leading Egyptian pharmaceutical company, for PEGylation of an undisclosed established biological medicine using TheraPEG. See press release.